UCL Department of Primary Care & Population Health, UCL Medical School, London, UK
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
BMJ Open. 2021 Dec 21;11(12):e051560. doi: 10.1136/bmjopen-2021-051560.
Vitamin D deficiency is associated with chronic obstructive pulmonary disease (COPD). We examined the cross-sectional association between 25-hydroxyvitamin D (25(OH)D) and lung function impairment and assessed whether vitamin D deficiency is related to long-term mortality in those with impaired lung function.
Prospective study SETTING: General practices in the UK.
3575 men aged 60-79 years with no prevalent heart failure.
Airway obstruction and mortality. The Global Initiative on Obstructive Lung diseases (GOLD) spirometry criteria was used to define airway obstruction.
During the follow-up period of 20 years, there were 2327 deaths (114 COPD deaths). Vitamin D deficiency was defined as serum 25(OH)D levels<10 ng/mL; insufficiency as 25(OH)D 10-19 ng/mL; sufficient as 25(OH)D>20 ng/mL. In cross-sectional analysis, vitamin D deficiency was more prevalent in those with moderate COPD (FEV/FVC <70% and FEV 50 to <80%; FEV, forced expiratory volume in 1 s and FVC, forced vital capacity) and severe COPD (FEV/FVC <70% and FEV <50%) but not in those with mild COPD (FEV/FVC <70% and FEV80%) or restrictive lung disease (FEV/FVC 70% and FVC <80%) compared with men with normal lung function . Vitamin D deficiency was associated with increased risk of total and respiratory mortality in both men with COPD and men with restrictive lung disease after adjustment for confounders and inflammation. The adjusted HRs (95% CI) for total mortality comparing levels of 25(OH)D<10 ng/mL to 25(OH)D>=20 ng/mL were 1.39 (1.10 to 1.75), 1.52 (1.17 to 1.98), 1.58 (1.17 to 2.14) and 1.39 (0.83 to 2.33) for those with no lung impairment, restrictive lung function, mild/moderate COPD and severe COPD, respectively.
Men with COPD were more likely to be vitamin D deficient than those with normal lung function. Vitamin D deficiency is associated with increased all-cause mortality in older men with no lung impairment as well as in those with restrictive or obstructive lung impairment.
维生素 D 缺乏与慢性阻塞性肺疾病(COPD)有关。我们研究了 25-羟维生素 D(25(OH)D)与肺功能损害之间的横断面关系,并评估了维生素 D 缺乏是否与肺功能受损患者的长期死亡率有关。
前瞻性研究。
英国的普通诊所。
3575 名年龄在 60-79 岁、无明显心力衰竭的男性。
气道阻塞和死亡率。使用全球倡议阻塞性肺疾病(GOLD)肺量计标准来定义气道阻塞。
在 20 年的随访期间,有 2327 人死亡(114 人死于 COPD)。维生素 D 缺乏定义为血清 25(OH)D 水平<10ng/ml;不足为 25(OH)D 10-19ng/ml;充足为 25(OH)D>20ng/ml。在横断面分析中,中度 COPD(FEV/FVC<70%和 FEV 50-<80%;FEV,1 秒用力呼气量和 FVC,用力肺活量)和重度 COPD(FEV/FVC<70%和 FEV<50%)患者中维生素 D 缺乏更为常见,但在轻度 COPD(FEV/FVC<70%和 FEV 80%)或限制性肺疾病(FEV/FVC 70%和 FVC<80%)患者中并非如此。与肺功能正常的男性相比,维生素 D 缺乏与 COPD 男性和限制性肺病男性的全因和呼吸死亡风险增加相关。在调整混杂因素和炎症后,比较 25(OH)D<10ng/ml 与 25(OH)D>=20ng/ml 水平时,总死亡率的调整 HR(95%CI)分别为 1.39(1.10-1.75)、1.52(1.17-1.98)、1.58(1.17-2.14)和 1.39(0.83-2.33),分别为无肺损伤、限制性肺功能、轻度/中度 COPD 和重度 COPD 的男性。
与肺功能正常的男性相比,COPD 男性更易出现维生素 D 缺乏。维生素 D 缺乏与无肺损伤以及阻塞性或限制性肺损伤的老年男性全因死亡率增加有关。